Literature DB >> 21709210

Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.

Neeraj Dhaun, Neil R Johnston, Jane Goddard, David J Webb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21709210     DOI: 10.1161/HYPERTENSIONAHA.111.175646

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  6 in total

1.  Chronic blockade of endothelin A and B receptors using macitentan in experimental renovascular disease.

Authors:  Nathan A Tullos; Nicholas J Stewart; Ryan Davidovich; Alejandro R Chade
Journal:  Nephrol Dial Transplant       Date:  2014-11-21       Impact factor: 5.992

Review 2.  Endothelin receptor antagonists for pulmonary arterial hypertension.

Authors:  Chao Liu; Junmin Chen; Yanqiu Gao; Bao Deng; Kunshen Liu
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 3.  Endothelin, kidney disease, and hypertension.

Authors:  Joshua S Speed; David M Pollock
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

4.  Endothelin receptor antagonists for pulmonary arterial hypertension.

Authors:  Chao Liu; Junmin Chen; Yanqiu Gao; Bao Deng; Kunshen Liu
Journal:  Cochrane Database Syst Rev       Date:  2021-03-26

5.  A novel role for myeloid endothelin-B receptors in hypertension.

Authors:  Alicja Czopek; Rebecca Moorhouse; Léa Guyonnet; Tariq Farrah; Olivia Lenoir; Elizabeth Owen; Job van Bragt; Hannah M Costello; Filippo Menolascina; Véronique Baudrie; David J Webb; David C Kluth; Matthew A Bailey; Pierre-Louis Tharaux; Neeraj Dhaun
Journal:  Eur Heart J       Date:  2019-03-01       Impact factor: 29.983

6.  Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension.

Authors:  Pierre Verweij; Parisa Danaietash; Bruno Flamion; Joël Ménard; Marc Bellet
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.